Mepilex® Border Heel Foam Dressing, 18.5cm x 24cm
Mepilex® Border Heel dressing is the only five-layer foam heel dressing proven to prevent pressure ulcers when used with other standard prevention protocols 1 2 3 4 5 .
This all-in-one dressing design also creates an optimal healing environment for managing moderate- to high-exuding wounds on the heel. It effectively absorbs and retains exudate 6 7 and it balances moisture properly avoiding the risk of maceration 8 9 .
The design also includes Safetac® – the original less-pain contact layer with silicone adhesion. So the dressing moulds softly to skin without sticking to the moist wound 8 – you can remove it easily without damaging the skin 10 11. That means less pain for your patients 12.
- Proven to prevent pressure ulcers – when used with other standard prevention protocols 1 2
- Protects against the extrinsic factors that cause pressure ulcers – pressure, shear, friction and micro-climate 3 4 13 14
- Mepilex Border with Safetac technology minimises pain during dressing changes 8
- Excellent fluid-handling capacity and retention
- Reduces risk of maceration 9
When to use Mepilex Border Heel
Mepilex ® Border Heel is specifically designed to fit the heel. The five-layer absorbent foam structure effectively manages exudate and the wound environment. So you can use it in the treatment of exuding wounds such as pressure ulcers, diabetic foot ulcers, heel ulcers, traumatic wounds, and other secondary healing wounds.
Pressure ulcer prevention
Mepilex Border Heel has been proven to prevent pressure ulcers 1 . You can apply the dressings prophylactically for at-risk patients 2 , such as the immobile, those with poor skin perfusion and impaired skin condition, in emergency rooms, in intensive care, or before and during long surgical interventions. Scientific studies have demonstrated that Mepilex Border Heel has the ability to impact four extrinsic factors that can contribute to developing pressure ulcers: by minimising and redistributing shear, redistributing pressure, reducing friction and maintaining an optimal microclimate 1 .
Note: using dressings as a prophylactic therapy does not replace the need a comprehensive pressure ulcer prevention protocol.
- Santamaria N, et al. Clinical effectiveness of a silicone foam dressing for the prevention of heel pressure ulcers in critically ill patients: Border II Trial. J Wound Care. 2015;24(8):340-345.
- Tayyib N, et al. Effectiveness of pressure ulcer prevention strategies for adult patients in intensive care units: a systematic review. Worldviews Evid Based Nurs 2016;13(6):432-444.
- Levy A, et al. The biomechanical efficacy of dressings in preventing heel ulcers. J Tissue Viability. 2015;24(1) :1-11.
- Levy A, et al. Computer modeling studies to assess whether a prophylactic dressing reduces the risk for deep tissue injury in the heels of supine patients with diabetes. Ostomy Wound Manage. 2016;62(4) :42-52.
- World Union of Wound Healing Societies (WUWHS). Consensus Document: Role of dressings in pressure ulcer prevention. London, UK: Wounds Int; 2016.
- Feili F. A laboratory evaluation of the fluid management capacities of absorbent foam dressings. Poster presentation at EWMA conference, Vienna, Austria, 23-25 May 2012.
- Feili F, et al. Retention capacity. Poster presentation at EWMA Conference, Lisbon, Portugal, 14-16 May 2008.
- White R. Evidence for atraumatic soft silicone wound dressing use. Wounds UK. 2005;1(3):104-109.
- Wiberg AB, et al. Preventing maceration with a soft silicone dressing: in-vitro evaluations. Poster presented at the 3rd Congress of WUWHS, Toronto, Canada. 4-8 June 2008.
- Call E, et al. Enhancing pressure ulcer prevention using wound dressings: what are the modes of action? Int Wound J. 2015 [cited 14 Sep 2017];12(4):408-413. URL: doi:10.1111/iwj.12123.
- Call E, et al. Microclimate impact of prophylactic dressings using in vitro body analogue method. Wounds. 2013;25(4):94-103.
- White R. A multinational survey of the assessment of pain when removing dressings. Wounds UK. 4 (1). 2008.
- SMTL external lab reports: 10/3299/1, 3F016961, 16/5164/2, 15/4934/1, FX214298 and 16/5209/1.